We are live on !
Find out more
John Overdeck Two Sigma Investments
AUM
$138B
Turnover
29.02%
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter Est. Return
+0.42%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.66%
AUM
$44.7B
AUM Growth
+$661M
(+1.5%)
Cap. Flow
+$492M
Cap. Flow % of AUM
Cap. Flow %
1.1%
Top 10 Holdings %
Top 10 Hldgs %
5.23%
Holding
4,966
New
996
Increased
1,597
Reduced
1,537
Closed
789
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
0
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$251M |
| 2 |
Eli Lilly
LLY
|
+$246M |
| 3 |
Cisco
CSCO
|
+$226M |
| 4 |
Chevron
CVX
|
+$224M |
| 5 |
Mastercard
MA
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$262M |
| 2 |
Block Inc
XYZ
|
+$236M |
| 3 |
Target
TGT
|
+$228M |
| 4 |
TJX Companies
TJX
|
+$222M |
| 5 |
Roku
ROKU
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.11% |
| 2 | Technology | 16.4% |
| 3 | Healthcare | 15.24% |
| 4 | Consumer Discretionary | 8.52% |
| 5 | Financials | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Alphabet (Google) Class A
GOOGL
$3.97T
| $246M | 0.55% |
1,838,360
-21,580
| -1% | -$2.94M |
2019 Q2
9 quarters
|
|
2
Microsoft
MSFT
$3.87T
| $243M | 0.54% |
860,742
+538,459
| +167% | +$157M |
2019 Q2
9 quarters
|
|
3
Caterpillar
CAT
$324B
| $236M | 0.53% |
1,229,107
+575,926
| +88% | +$120M |
2021 Q1
2 quarters
|
|
4
Visa
V
$778B
| $235M | 0.53% |
1,055,629
-27,412
| -3% | -$6.43M |
2019 Q2
9 quarters
|
|
5
Citigroup
C
$206B
| $232M | 0.52% |
3,300,832
+408,975
| +14% | +$28.6M |
2019 Q4
7 quarters
|
|
|
6
Eli Lilly
LLY
$1.16T
| $230M | 0.51% |
+996,910
| New | +$246M |
2021 Q3
0 quarters
|
|
|
7
PayPal
PYPL
$49.2B
| $230M | 0.51% |
+884,227
| New | +$251M |
2021 Q3
0 quarters
|
|
8
Charter Communications
CHTR
$12.8B
| $230M | 0.51% |
315,717
+196,997
| +166% | +$149M |
2018 Q4
11 quarters
|
|
|
9
Chevron
CVX
$445B
| $229M | 0.51% |
2,260,655
+2,247,131
| +16,616% | +$224M |
2021 Q2
1 quarter
|
|
10
Booking.com
BKNG
$121B
| $228M | 0.51% |
2,397,700
+620,550
| +35% | +$55.7M |
2021 Q2
1 quarter
|
|
11
Mondelez International
MDLZ
$83.2B
| $227M | 0.51% |
3,906,905
+1,332,903
| +52% | +$82.9M |
2020 Q4
3 quarters
|
|
12
Amgen
AMGN
$242B
| $226M | 0.51% |
1,064,945
+125,064
| +13% | +$28.8M |
2021 Q2
1 quarter
|
|
13
Merck
MRK
$363B
| $225M | 0.5% |
3,001,787
-190,330
| -6% | -$14.5M |
2019 Q2
9 quarters
|
|
|
14
Cisco
CSCO
$414B
| $223M | 0.5% |
4,094,473
+4,035,970
| +6,899% | +$226M |
2016 Q1
22 quarters
|
|
15
Intel
INTC
$452B
| $222M | 0.5% |
4,169,265
+324,673
| +8% | +$17.6M |
2017 Q1
18 quarters
|
|
16
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $222M | 0.5% |
516,200
+440,100
| +578% | +$194M |
2015 Q1
26 quarters
|
|
|
17
Mastercard
MA
$555B
| $221M | 0.49% |
636,176
+574,918
| +939% | +$209M |
2017 Q3
16 quarters
|
|
18
Coca-Cola
KO
$410B
| $221M | 0.49% |
4,205,962
-310,833
| -7% | -$17.3M |
2017 Q1
18 quarters
|
|
19
Upstart Holdings
UPST
$2.32B
| $220M | 0.49% |
+696,271
| New | +$137M |
2021 Q3
0 quarters
|
|
20
Qualcomm
QCOM
$185B
| $220M | 0.49% |
1,708,125
-155,368
| -8% | -$22M |
2017 Q3
16 quarters
|
|
21
Bristol-Myers Squibb
BMY
$129B
| $219M | 0.49% |
3,705,389
+34,680
| +0.9% | +$2.28M |
2018 Q3
12 quarters
|
|
22
S&P Global
SPGI
$134B
| $219M | 0.49% |
515,907
+230,144
| +81% | +$100M |
2018 Q4
11 quarters
|
|
23
Lam Research
LRCX
$288B
| $219M | 0.49% |
3,851,140
+3,192,880
| +485% | +$194M |
2021 Q2
1 quarter
|
|
24
Gilead Sciences
GILD
$195B
| $218M | 0.49% |
3,125,970
+2,392,373
| +326% | +$168M |
2021 Q2
1 quarter
|
|
25
Philip Morris
PM
$314B
| $216M | 0.48% |
2,275,697
+1,831,259
| +412% | +$184M |
2020 Q4
3 quarters
|
|
Similar funds
John Overdeck's Q3 2021 Portfolio in Review
As of Q3 2021, John Overdeck held 4,966 positions worth $44.7B, up 1.5% from $44.1B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
John Overdeck's Q3 2021 filing shows 996 new, 1,597 increased, 1,537 reduced and 789 closed positions. Its largest new stake was PayPal: 884,227 shares worth $230M. The largest sale was Pfizer, an estimated $262M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
- John Overdeck's largest Q3 2021 buy was PayPal: 884,227 shares worth $230M.
- John Overdeck added most to Cisco in Q3 2021, an estimated $226M increase.
- John Overdeck's biggest Q3 2021 reduction was Block Inc, cutting an estimated $236M.
- John Overdeck fully exited Pfizer in Q3 2021, selling an estimated $262M.
- John Overdeck's ten largest holdings make up 5.2% of its $44.7B portfolio in Q3 2021.
- John Overdeck opened 996 new positions and closed 789 in Q3 2021.
- John Overdeck's portfolio value rose 1.5% quarter-over-quarter to $44.7B.
Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.